3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Neoplasms
1
Metastatic Urothelial Cancer
1
Kidney Neoplasms
1
Kidney Diseases
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Interventions
enfortumab vedotin
2
pembrolizumab
1
avelumab
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Urologic Neoplasms
×
avelumab
×
Clear all
NCT02603432
2024-03-27
JAVELIN Bladder 100
Pfizer
Phase 3
Completed
700 enrolled
35 charts
1 FDA